Rowena J. Dolor, MD, MHS did her medical training and internal medicine residency at Duke University Medical Center. She completed the Ambulatory Care/Health Services Research fellowship at the Durham VA Medical Center in 1996 and obtained her Masters in Health Sciences degree in Biometry from the Duke University School of Medicine in 1998. Dr. Dolor is a staff physician in the Ambulatory Care Service at the Durham VA Medical Center and Research Associate at the Center for Health Services Research in Primary Care at the Durham VAMC since 1995. Dr. Dolor is the Site Investigator and a member of the Executive and Steering Committees for CSP #481, The Home INR Study (THINRS). She is currently an investigator of several federally-funded projects conducted in the community-based setting on hypertension, patient-provider communication, immunization, and medication therapy management. Dr. Dolor serves as a member of the AHRQ PBRN Resource Center Steering Committee.
Since 1997, Dr. Dolor has been the director of the Primary Care Research Consortium (PCRC), a network of primary care practices in the Duke University Health System and outlying communities. The PCRC has participated in over 50 industry- and investigator-initiated studies on hypertension, hyperlipidemia, asthma, otitis, obesity, diabetes, depression, anticoagulation, and vaccines. In 2002, the Duke PCRC received grant funding from the Agency for Healthcare Research and Quality (AHRQ) for Primary Care Practice-based Research Networks (PBRNs). The focus of her research pertains to primary care clinical and outcomes research. She has helped lead a number of medical, surgical, and outcomes studies, including the CAFFS trial that determined the outcomes of treating recurrent sinus infections with nasal steroids, and the ARTIST study on the similar effectiveness of selective serotonin reuptake inhibitors in primary care depression.
In 1996, Dr. Dolor was the founding co-director, along with David Witsell, MD MHS, of the Surgeon’s Outcomes Research Cooperative in Otorhinolaryngology (SOURCE). This was a network of academic and community otolaryngology and primary care sites with an interest in common ear, nose, and throat (ENT) disorders, e.g. sinusitis and otitis media. The SOURCE network has been renamed as the Building Evidence for Successful Treatments in Otolaryngology (BEST ENT) and is now supported by the AAO-HNS Foundation and the Duke Clinical Research Institute.
As a result of Dr. Dolor’s experience in building networks in otolaryngology and primary care, Dr. Dolor received funding in July 2007 to be co-director of the Bravewell Integrative Medicine Research Network (BraveNet). BraveNet is a PBRN of seven integrative medicine centers in the U. S. with a mission to evaluate integrative medicine approaches through cross-sectional and longitudinal collection of data in patient characteristics, utilization patterns, safety and costs.
As a senior fellow for CCHPR she was a co-investigator on the AHRQ Evidence Report on the Management of Allergic Rhinitis in the Working-Age Population and principal investigator for the systematic literature review for the AHA Scientific Statement: Evidence-based guidelines for cardiovascular disease prevention in women published in 2004 and updated in 2007.
In 2007, she was appointed the Medical Director for the Primary Care Site-Based Research (SBR) group at Duke University Medical Center, which includes responsibility for overseeing the quality, financial performance, regulatory compliance, and academic output of all clinical research studies conducted within Primary Care (Family Medicine, General Internal Medicine, and General Pediatrics).
In addition to her clinical practice and research, Dr. Dolor is co-chair of the Eugene A. Stead Jr. Scholarship Committee and a member of the Duke Medical Alumni Council. She has also served as co-chair and